Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow‐up study

J.F. Timp; W.M. Lijfering; L.E. Flinterman; A. van Hylckama Vlieg; S. Le Cessie; F.R. Rosendaal; S.C. Cannegieter

doi:10.1111/jth.13113

journal article Open Access Oct 01, 2015

Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow‐up study

J.F. Timp W.M. Lijfering L.E. Flinterman A. van Hylckama Vlieg S. Le Cessie F.R. Rosendaal S.C. Cannegieter

Journal of Thrombosis and Haemostasis Vol. 13 No. 10 pp. 1823-1832 · Elsevier BV

View at Publisher Save 10.1111/jth.13113

Topics

No keywords indexed for this article. Browse by subject →

References

38

[1]

Naess "Incidence and mortality of venous thrombosis: a population‐based study" J Thromb Haemost (2007) 10.1111/j.1538-7836.2007.02450.x

[2]

Hansson "Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors" Arch Intern Med (2000) 10.1001/archinte.160.6.769

[3]

Heit "Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population‐based cohort study" Arch Intern Med (2000) 10.1001/archinte.160.6.761

[4]

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

Paolo Prandoni, Anthonie W.A. Lensing, Alberto Cogo et al.

Annals of Internal Medicine 1996 10.7326/0003-4819-125-1-199607010-00001

[5]

Kearon "Comparison of low‐intensity warfarin therapy with conventional‐intensity warfarin therapy for long‐term prevention of recurrent venous thromboembolism" N Engl J Med (2003) 10.1056/nejmoa035422

[6]

Ridker "Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism" N Engl J Med (2003) 10.1056/nejmoa035029

[7]

Kearon "Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines" Chest (2012) 10.1378/chest.11-2301

[8]

Bauer "Long‐term management of venous thromboembolism: a 61‐year‐old woman with unprovoked venous thromboembolism" JAMA (2011) 10.1001/jama.2011.361

[9]

Jenkins "Elevated factor VIII levels and risk of venous thrombosis" Br J Haematol (2012) 10.1111/j.1365-2141.2012.09134.x

[10]

Kraaijenhagen "High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism" Thromb Haemost (2000) 10.1055/s-0037-1613747

[11]

O'Donnell "Elevation of FVIII:C in venous thromboembolism is persistent and independent of the acute phase response" Thromb Haemost (2000) 10.1055/s-0037-1613748

[12]

Tichelaar "The acute phase reaction explains only a part of initially elevated factor VIII:C levels: a prospective cohort study in patients with venous thrombosis" Thromb Res (2012) 10.1016/j.thromres.2011.09.024

[13]

Eichinger "Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model" Circulation (2010) 10.1161/circulationaha.109.925214

[14]

Rodger "Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy" CMAJ (2008) 10.1503/cmaj.080493

[15]

Tosetto "Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)" J Thromb Haemost (2012) 10.1111/j.1538-7836.2012.04735.x

[16]

Kyrle "High plasma levels of factor VIII and the risk of recurrent venous thromboembolism" N Engl J Med (2000) 10.1056/nejm200008173430702

[17]

Lijfering "Contribution of high factor VIII, IX and XI to the risk of recurrent venous thrombosis in factor V Leiden carriers" J Thromb Haemost (2009) 10.1111/j.1538-7836.2009.03580.x

[18]

Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis

Jeanet W. Blom

JAMA 2005 10.1001/jama.293.6.715

[19]

Meltzer "Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis" PLoS Med (2008) 10.1371/journal.pmed.0050097

[20]

Flinterman "Long‐term survival in a large cohort of patients with venous thrombosis: incidence and predictors" PLoS Med (2012) 10.1371/journal.pmed.1001155

[21]

Levesque "Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes" BMJ (2010) 10.1136/bmj.b5087

[22]

Lenting "The life cycle of coagulation factor VIII in view of its structure and function" Blood (1998) 10.1182/blood.v92.11.3983

[23]

Baglin "High risk of recurrent venous thromboembolism in men" J Thromb Haemost (2004) 10.1111/j.1538-7836.2004.01050.x

[24]

Christiansen "Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event" J Thromb Haemost (2010) 10.1111/j.1538-7836.2010.03994.x

[25]

Gandara "Non‐OO blood type influences the risk of recurrent venous thromboembolism. A cohort study" Thromb Haemost (2013) 10.1160/th13-06-0488

[26]

Koster "Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep‐vein thrombosis" Lancet (1995) 10.1016/s0140-6736(95)90166-3

[27]

Newson "Comparing the predictive powers of survival models using Harrell's C or Somers' D" Stata J (2010) 10.1177/1536867x1001000303

[28]

Christiansen "Thrombophilia, clinical factors, and recurrent venous thrombotic events" JAMA (2005) 10.1001/jama.293.19.2352

[29]

Cristina "High plasma levels of factor VIII and risk of recurrence of venous thromboembolism" Br J Haematol (2004) 10.1046/j.1365-2141.2003.04795.x

[30]

Wells "Elevated factor VIII is a risk factor for idiopathic venous thromboembolism in Canada – is it necessary to define a new upper reference range for factor VIII?" Thromb Haemost (2005) 10.1160/th05-01-0013

[31]

Lijfering "Risk factors for venous thrombosis – current understanding from an epidemiological point of view" Br J Haematol (2010) 10.1111/j.1365-2141.2010.08206.x

[32]

Meijer "The absence of ‘minor’ risk factors for recurrent venous thromboembolism: a systematic review of negative predictive values and negative likelihood ratios" J Thromb Haemost (2009) 10.1111/j.1538-7836.2009.03557.x

[33]

Cosmi "D‐dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep‐vein thrombosis" Thromb Haemost (2011) 10.1160/th10-08-0559

[34]

Cosmi "Usefulness of repeated D‐dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study" Blood (2010) 10.1182/blood-2009-08-237354

[35]

Palareti "D‐dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study" Blood (2014) 10.1182/blood-2014-01-548065

[36]

Adcock "The effect of dabigatran on select specialty coagulation assays" Am J Clin Pathol (2013) 10.1309/ajcpy6g6zitvkpvh

[37]

Tichelaar "Interference of rivaroxaban in one‐stage and chromogenic factor VIII:C assays" Thromb Haemost (2011) 10.1160/th11-04-0277

[38]

Carrier "Systematic review: case‐fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism" Ann Intern Med (2010) 10.7326/0003-4819-152-9-201005040-00008

Metrics

67

Citations

38

References

Details

Published: Oct 01, 2015
Vol/Issue: 13(10)
Pages: 1823-1832
License: View

Authors

A. van Hylckama Vlieg

Funding

Netherlands Organization for Scientific Research Award: 912-03-033|2003

Netherlands Heart Foundation Award: NHS98.113

Dutch Cancer Foundation Award: RUL 99/1992

Cite This Article

J.F. Timp, W.M. Lijfering, L.E. Flinterman, et al. (2015). Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow‐up study. Journal of Thrombosis and Haemostasis, 13(10), 1823-1832. https://doi.org/10.1111/jth.13113

Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow‐up study

You May Also Like